Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $995.76 ($99K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($99k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $979.40 | 2 | $2K | 2.0% |
| 2 | $980.16 | 3 | $3K | 3.0% |
| 3 | $981.95 | 3 | $3K | 3.0% |
| 4 | $982.99 | 1 | $983 | 1.0% |
| 5 | $984.52 | 2 | $2K | 2.0% |
| 6 | $988.66 | 2 |
| $2K |
| 2.0% |
| 7 | $990.74 | 4 | $4K | 4.0% |
| 8 | $992.19 | 7 | $7K | 7.0% |
| 9 | $993.20 | 12 | $12K | 12.0% |
| 10 | $994.25 | 5 | $5K | 5.0% |
| 11 | $995.76 | 6 | $6K | 6.0% |
| 12 | $996.83 | 12 | $12K | 12.0% |
| 13 | $997.76 | 15 | $15K | 15.0% |
| 14 | $998.44 | 14 | $14K | 14.1% |
| 15 | $999.43 | 7 | $7K | 7.0% |
| 16 | $1000.04 | 5 | $5K | 5.0% |
| Total | $994.50 avg | 100 | $99K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |